Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients

Giacomo Adoncecchi, MS, Ambuj Kumar, MD MPH, Rawan Faramand, MD, Hien D. Liu, MD, Farhad Khimani, MD, Asmita Mishra, MD, Michael Nieder, MD, Taiga Nishihori, MD, Lia Perez, MD, Joseph Pidala, MD, Claudio Anasetti, MD, Nelli Bejanyan, MD, Hany Elmariah, MDMS

Blood (2020) 136 (Supplement 1): 27.

https://doi.org/10.1182/blood-2020-141966

Published: 2020

Journal Articles

Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis

Madiha Iqbal, MBBS, Tea Reljic, MPH, Ernesto Ayala, MD, Hemant S. Murthy, MD, Ambuj Kumar, MD MPH, Mohamed A Kharfan-Dabaja, MDMBA

Blood (2019) 134 (Supplement_1): 2106.

https://doi.org/10.1182/blood-2019-124955

Published: 2019

Journal Articles

Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant

Sayeef Mirza, MDMPH, Ankita Tandon, DO, Dakota Jenneman, MD, Shu Cao, MD, Ambuj Kumar, MD MPH, Michelle R. Kidd, PharmD, Farhad Khimani, MD, Asmita Mishra, MD, Hien D. Liu, MD, Taiga Nishihori, MD, Lia Perez, MD, Nelli Bejanyan, MD, Joseph Pidala, MD, Michael Nieder, MD, Hany Elmariah, MD MS

Blood (2019) 134 (Supplement_1): 5673.

https://doi.org/10.1182/blood-2019-127370

Published: 2019

Journal Articles

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Maya Khalil, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Mehdi Hamadani, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Ambuj Kumar, MD MPH, Mohamed A Kharfan-Dabaja, MD

Blood (2016) 128 (22): 3551.

https://doi.org/10.1182/blood.V128.22.3551.3551

Published: 2016

Journal Articles

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

Jessica El-Asmar, MD, Tea Reljic, MPH, Ernesto Ayala, MD, Taiga Nishihori, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH, Mohamed A. Kharfan-Dabaja, MD

Blood (2015) 126 (23): 4493.

https://doi.org/10.1182/blood.V126.23.4493.4493

Published: 2015

Journal Articles

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH

Blood (2015) 126 (23): 2097.

https://doi.org/10.1182/blood.V126.23.2097.2097

Published: 2015

Journal Articles

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Tea Reljic, M.S., Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD, Mohamed A Kharfan-Dabaja, MD

Blood (2014) 124 (21): 1306.

https://doi.org/10.1182/blood.V124.21.1306.1306

Published: 2014

Journal Articles

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Tea Reljic, BS, Ambuj Kumar, MD, MPH, Helen Mahoney, MPH, Branko Miladinovic, PhD, Mohamed A Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 1945.

https://doi.org/10.1182/blood.V122.21.1945.1945

Published: 2013

Journal Articles

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Jasmin Lacevic, Tea Reljic, BS, Najla El Jurdi, MD, Mohamed A Kharfan-Dabaja, MD, Taiga Nishihori, MD, Rami S. Komrokji, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 5372.

https://doi.org/10.1182/blood.V122.21.5372.5372

Published: 2013

Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 236.

https://doi.org/10.1182/blood.V120.21.236.236

Published: 2012

Journal Articles

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Mehdi Hamadani, M.D, Tea Reljic, William I. Bensinger, MD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4519.

https://doi.org/10.1182/blood.V120.21.4519.4519

Published: 2012

Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 4271.

https://doi.org/10.1182/blood.V120.21.4271.4271

Published: 2012

Journal Articles

Social Network Analysis (SNA) of Salvage Therapies in Multiple Myeloma (MM)

Helen Mahony, MPH, Athanasios Tsalatsanis, PhD, Rahul Mhaskar, MPH, PhD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 4239.

https://doi.org/10.1182/blood.V120.21.4239.4239

Published: 2012

Journal Articles

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Mohamed A. Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Tea Reljic, Joseph Pidala, MD, MS, Janelle Perkins, PharmD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4168.

https://doi.org/10.1182/blood.V120.21.4168.4168

Published: 2012

Journal Articles

Trial Sequential Analysis in Meta-Analyses of Maintenance Therapies for Multiple Myeloma.

Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Helen Mahoney, MPH, Keith Wheatley, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 2975.

https://doi.org/10.1182/blood.V120.21.2975.2975

Published: 2012

Journal Articles

Impact of National Cancer Institute's Common Toxicity Criteria and Common Terminology Criteria for Adverse Events on Quality of Treatment Related Harms Reporting: An Analysis of National Cancer Institute's Co-Operative Group Phase III Randomized Controlled Trials

Rahul Mhaskar, MPH, PhD, Hesborn Wao, PhD, Tea Reljic, BS, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2011) 118 (21): 673.

https://doi.org/10.1182/blood.V118.21.673.673

Published: 2011

Journal Articles

External Validation of Prognostic Models in Terminally Ill Patients,

Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Athanasios Tsalatsanis, PhD, Alfred Mbah, PhD, Ambuj Kumar, MD, MPH, Kim Sehwan, PhD, Ronald Schonwetter, MD, Benjamin Djulbegovic, MD, PhD

Blood (2011) 118 (21): 4186.

https://doi.org/10.1182/blood.V118.21.4186.4186

Published: 2011

Journal Articles

Social Network Analysis (SNA) of Research Programs In Multiple Myeloma (MM)

Helen Georgiev, MPH, Athanasios Tsalatsanis, PhD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2011) 118 (21): 3144.

https://doi.org/10.1182/blood.V118.21.3144.3144

Published: 2011

Journal Articles

Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials

Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH, Branko Miladinovic, PhD, Asmita Mhaskar, MPH, Tea Reljic, BS, Sanja Galeb, BS, Rahul Mhaskar, MPH, PhD, Hozo Iztok, PhD, Dongsheng Tu, Heather Stanton, Christopher M Booth, Ralph M. Meyer, MD

Blood (2011) 118 (21): 508.

https://doi.org/10.1182/blood.V118.21.508.508

Published: 2011

Journal Articles

Comparative Effectiveness of Bisphoshonates In Multiple Myeloma

Rahul Mhaskar, MD, MPH, Jasmina Redzepovic, Keith Wheatley, Otavio Clark, Axel Glasmacher, MD, Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2010) 116 (21): 3028.

https://doi.org/10.1182/blood.V116.21.3028.3028

Published: 2010

NARROW

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients

Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis

Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis

Social Network Analysis (SNA) of Salvage Therapies in Multiple Myeloma (MM)

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Trial Sequential Analysis in Meta-Analyses of Maintenance Therapies for Multiple Myeloma.

Impact of National Cancer Institute's Common Toxicity Criteria and Common Terminology Criteria for Adverse Events on Quality of Treatment Related Harms Reporting: An Analysis of National Cancer Institute's Co-Operative Group Phase III Randomized Controlled Trials

External Validation of Prognostic Models in Terminally Ill Patients,

Social Network Analysis (SNA) of Research Programs In Multiple Myeloma (MM)

Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials

Comparative Effectiveness of Bisphoshonates In Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only